Abstract
Chlamydia trachomatis infections are a global health problem. This obligate intracellular bacterial pathogen comprises lymphogranuloma venereum (L1-L3), ocular (A-C) and genital (D-K) serovars. Although genetically similar, each serovar group differs in disease severity and tissue tropism through mechanisms that are not well understood. It is clear that host genetic differences also play a role in chlamydial disease outcome and key host polymorphisms are beginning to emerge from both human and experimental animal studies. In this review, we will highlight pathogen and host genes that link genetic diversity, disease severity and tissue tropism. We will also use this information to provide new insights that may be helpful in developing improved management strategies for these important pathogens.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1129-1146 |
| Number of pages | 18 |
| Journal | Future Microbiology |
| Volume | 8 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 2013 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chlamydia trachomatis
- disease severity
- gene polymorphisms
- genetic variation
- genital tract infections
- tissue tropism
ASJC Scopus subject areas
- Microbiology
- Microbiology (medical)
Fingerprint
Dive into the research topics of 'Genetic variation in Chlamydia trachomatis and their hosts: Impact on disease severity and tissue tropism'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS